Video Experimental Relacionado
Updated: May 7, 2026

08:50
Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
7.4K
DIP2B como biomarcador pronóstico y objetivo de la inmunoterapia: información del análisis pancancerígeno
Hai Bai1, Yue Cao2,3, Guozheng Wei2,4
1Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China.
Applied biochemistry and biotechnology
|January 4, 2026
Resumen
No abstract available in PubMed .
Palabras clave:
La bioinformáticaDIP2B (en inglés)La inmunoterapiaCáncer de páncreasBiomarcador de pronósticoMás Videos Relacionados
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
5.6K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
2.1K